SHERYL DREW: Open Payments
NPI 1154096543 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 19 payments from 7 companies in 2025. Trend: 2023 $15 · 2024 $156 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $306 |
| AstraZeneca Pharmaceuticals LP | 5 | $283 |
| Eisai Inc. | 3 | $172 |
| Exact Sciences Corporation | 1 | $24 |
| Vertex Pharmaceuticals Incorporated | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Braeburn Inc. | 1 | $19 |
Products named: CAPLYTA, Leqembi, BREZTRI, AIRSUPRA, Cologuard Collection Kit, JOURNAVX, Ozempic, BRIXADI.
Industry payments across FL — which companies pay providers there.
